Skip to main content

Table 1 Demographics, comorbidities, and reason for admission

From: Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsis

Variable

Entire Cohort (n = 104)

1-year survivors* (n = 74)

1-year non-survivors* (n = 24)

P value

Age in years, median (25th, 75th)

63 (51, 72)

60 (44, 70)

69 (56, 77)

0.026

Male, n (%)

57 (55)

38 (51)

15 (63)

0.36

Race, n (%)

   

0.19

 Caucasian (White)

96 (92)

67 (91)

24 (100)

 

 African American

8 (8)

7 (10)

0 (0)

 

 Statin use, n (%)

33 (32)

22 (30)

8 (33)

0.76

 Charlson Comorbidity Index, median (25th, 75th)

3 (1, 4)

2 (0, 4)

4 (3, 5)

0.002

Comorbidities, n (%)

 Solid cancer

13 (13)

8 (11)

4 (17)

0.48

 Hematologic cancer

0 (0)

0 (0)

0 (0)

N/A

 Dementia

4 (4)

4 (5.4)

0 (0)

0.57

 Heart failure

9 (9)

7 (10)

2 (8)

1

 Liver disease

2 (2)

2 (3)

0 (0)

1

 Chronic lung disease

15 (14)

11 (15)

4 (17)

1

 Chronic renal disease

14 (13)

9 (12)

4 (17)

0.73

 Prior stroke

11 (11)

7 (10)

3 (13)

0.70

 Coronary disease

27 (26)

17 (23)

9 (38)

0.19

 Diabetes

37 (36)

27 (37)

9 (38)

1

 Substance abuse

4 (6)

4 (5)

0 (0)

0.57

 Hypertension

70 (67)

49 (66)

16 (67)

1

 Atrial fibrillation

15 (14)

9 (12)

4 (17)

0.73

 Morbid obesity

21 (20)

16 (22)

4 (17)

0.77

 Peripheral artery disease

7 (7)

4 (5)

3 (13)

0.36

Reason for hospital admission, n (%)

   

0.60

 Planned surgery

20 (19)

15 (20)

4 (17)

 

 Trauma

11 (11)

10 (14)

1 (4)

 

 Active infection

62 (60)

42 (57)

16 (67)

 

 Non-infectious/chronic problems

11 (11)

7 (10)

3 (13)

 

 Inter-facility transfer, n (%)

43 (41)

28 (38)

12 (50)

0.34

  1. *indicate that 6 patients were lost to follow up and did not have data on 1-year survival